Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2010, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2010-08-26
DOI
10.1155/2010/546826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
- (2009) Manju L. Subramanian et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- The role of the Angiopoietins in vascular morphogenesis
- (2009) Markus Thomas et al. ANGIOGENESIS
- Typing of ARMS2 and CFH in Age-Related Macular Degeneration
- (2009) Federico Ricci ARCHIVES OF OPHTHALMOLOGY
- Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
- (2009) Konstantin Gaengel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P)
- (2009) Dietmar W Siemann et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Expression of hypoxia-inducible factor−1α and −2α in human choroidal neovascular membranes
- (2009) Carl M. Sheridan et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Complement factor H and LOC387715 gene polymorphisms in a Greek population with age-related macular degeneration
- (2009) Dimitra I. Marioli et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- CCR3 is a target for age-related macular degeneration diagnosis and therapy
- (2009) Atsunobu Takeda et al. NATURE
- Elevated Plasma Levels of C3a Complement Compound in the Exudative Form of Age-Related Macular Degeneration
- (2009) Anna Machalińska et al. OPHTHALMIC RESEARCH
- Comparative Study of Intravitreal Bevacizumab (Avastin) versus Ranibizumab (Lucentis) in the Treatment of Neovascular Age-Related Macular Degeneration
- (2009) Gennady Landa et al. OPHTHALMOLOGICA
- Cerebrovascular Accidents in Ranibizumab
- (2009) Takashi Ueta et al. OPHTHALMOLOGY
- Economic Implications of Current Age-Related Macular Degeneration Treatments
- (2009) William E. Smiddy OPHTHALMOLOGY
- Complement Factor H Y402H and C-Reactive Protein Polymorphism and Photodynamic Therapy Response in Age-Related Macular Degeneration
- (2009) Xuefeng Feng et al. OPHTHALMOLOGY
- Intravitreal Bevacizumab and Ranibizumab for Age-Related Macular Degeneration
- (2009) Donald S. Fong et al. OPHTHALMOLOGY
- Impact of Coagulation-Balance Gene Predictors on Efficacy of Photodynamic Therapy for Choroidal Neovascularization in Pathologic Myopia
- (2009) Francesco Parmeggiani et al. OPHTHALMOLOGY
- Economic Burden of Bilateral Neovascular Age-Related Macular Degeneration
- (2009) Alan F Cruess et al. PHARMACOECONOMICS
- INTRAVITREAL BEVACIZUMAB FOR TREATMENT-NAÏVE PATIENTS WITH SUBFOVEAL OCCULT CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
- (2009) CIRO COSTAGLIOLA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2009) KIMBERLY E. STEPIEN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- ANALYSES OF SINGLE NUCLEOTIDE POLYMORPHISMS AND HAPLOTYPE LINKAGE OF LOC387715 AND THE HTRA1 GENE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION IN A CHINESE COHORT
- (2009) HUA JIANG et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- CONCENTRATION OF CYTOKINES IN THE AQUEOUS HUMOR OF PATIENTS WITH NAIVE, RECURRENT AND REGRESSED CNV ASSOCIATED WITH AMD AFTER BEVACIZUMAB TREATMENT
- (2009) MI IN ROH et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations
- (2008) Peep V. Algvere et al. ACTA OPHTHALMOLOGICA
- Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab
- (2008) A Y Lee et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism
- (2008) I Droz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Correlation betweenCFHY402H andHTRA1rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population
- (2008) Norimoto Gotoh et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Neovascular Age-Related Macular Degeneration
- (2008) Aimee V Chappelow et al. DRUGS
- Differences in the temporal expression of regulatory growth factors during choroidal neovascular development
- (2008) Wenzheng Hu et al. EXPERIMENTAL EYE RESEARCH
- Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy
- (2008) M A Brantley et al. EYE
- Vascular adhesion protein-1 blockade suppresses choroidal neovascularization
- (2008) Kousuke Noda et al. FASEB JOURNAL
- Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss
- (2008) P J Francis et al. JOURNAL OF MEDICAL GENETICS
- Inflammation, Complement Factor H, and Age-Related Macular Degeneration
- (2008) Ronald Klein et al. OPHTHALMOLOGY
- Alleles in the HtrA Serine Peptidase 1 Gene Alter the Risk of Neovascular Age-Related Macular Degeneration
- (2008) Margaret M. DeAngelis et al. OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- Predictive role of C677TMTHFRpolymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration
- (2008) Francesco Parmeggiani et al. PHARMACOGENOMICS
- Multifactor Effects and Evidence of Potential Interaction between Complement Factor H Y402H and LOC387715 A69S in Age-Related Macular Degeneration
- (2008) Sanna P. Seitsonen et al. PLoS One
- SURVEILLANCE FOR POTENTIAL ADVERSE EVENTS ASSOCIATED WITH THE USE OF INTRAVITREAL BEVACIZUMAB FOR RETINAL AND CHOROIDAL VASCULAR DISEASE
- (2008) LISA J. WONG et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- OUTCOME OF BEVACIZUMAB (AVASTIN) INJECTION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION AND LOW VISUAL ACUITY
- (2008) RITA EHRLICH et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Phenotype Analysis of Patients With the Risk Variant LOC387715 (A69S) in Age-related Macular Degeneration
- (2007) R. Keith Shuler et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation
- (2007) Eoin Guerin et al. MICROVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started